跳至主要内容
临床试验/NCT01538264
NCT01538264进行中(未招募)不适用

Blood Flow MRI for Monitoring of Glioma Angiogenesis

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
125
试验地点
1

研究概览

简要总结

The investigators are studying the use of an advanced magnetic resonance imaging (MRI) technique for measuring blood flow into brain tumors. This technique does not use radioactive tracers, and it can provide high quality images that can be obtained in a standard MRI scanner.

详细描述

Our goals are:

  1. To compare the blood flow measured with this technique with measures of tumor blood vessel density in pieces of the tumor surgically removed as a normal part of clinical treatment. This will confirm a relationship between the imaging measurements and the microscopic characteristics of tumors.
  2. To compare the blood flow in tumors before therapy with the concentration of choline, an indicator of cell proliferation. This choline concentration can be measured with another MRI technique. This information will demonstrate the relationship between cell proliferation and blood supply and will also determine whether the choline measurement adds additional information that is clinically necessary.
  3. To determine the reproducibility of blood flow measurements in tumors. This is necessary to better understand the sensitivity of the technique to changes in flow caused by a treatment or changes in tumor vascularity.
  4. To monitor changes in blood flow after initial treatment. Since sometimes tumors can reappear, the repeated measures will help determine how useful this new imaging technique is at detecting such recurring tumors.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with or are suspected of having a glioma

排除标准

  • contraindications to MRI which may include the following
  • MRI incompatible metal implant
  • Recently implanted vascular clip
  • History of claustrophobia
  • Metal fragment within the eye
  • Subjects who have received nonstandard therapy may be excluded if the therapy might alter tumor blood flow or other imaging characteristic.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Alsop

Professor of Radiology

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验